Two diabetes medications more beneficial in preventing major cardiovascular events

FHS
June 3, 2024
4:56 pm

GLP-1 receptor agonists (GLP-1s) and SGLT-2 inhibitors lower the risk of major cardiovascular events like heart attacks and severe liver complications compared to other diabetes treatments, according to data being presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.

Methadone treatment gets first major update in over 20 years

The federal government is unveiling new regulations meant to modernize methadone treatment, the first major update to patient care standards at methadone clinics in more

February 1, 2024

Blocking IL-11 protein extends lifespan and health in mice by 25%, study shows

Scientists at the Medical Research Council Laboratory of Medical Science and Imperial College London have discovered that ‘switching off’ a protein called IL-11 can significantly

July 18, 2024

Untangling Ron Desantis’ debate anecdote about an improbable abortion survival story

When the topic of abortion came up during the first Republican primary presidential debate this week, Florida Gov. Ron DeSantis shared a perplexing anecdote about

August 25, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.